WTW's second-quarter results confirmed the headline figures: US$625 million earmarked for its new Propel AI plan, roughly US$400 million in expected annual savings, a target of 30% adjusted operating margin by 2028. Those numbers describe an ambition. They don't describe what's running today, which is the part that matters more to any broker or insurer deciding whether to plug into WTW's systems.
Neuron, WTW's AI-powered placement platform, is already live in cyber placements in North America and in UK property business, with a wider rollout planned through the rest of this year, according to comments WTW made when it set out its AI strategy following the Newfront deal. On the international property facility that runs on Neuron, WTW says quotes can now be turned around in minutes rather than days, and the facility has grown to US$60 million of follow capacity per placement across territories spanning Europe, Asia, Australia and New Zealand, South Africa, Latin America, the Caribbean and Canada. Liberty Specialty Markets became an early adopter specifically to speed up how it trades follow business, and the two firms have since added live D&O and cyber trading to the platform. The pitch to insurers is simple: connect once, and gain access to a growing pool of brokers submitting more standardised, cleaner data.
Propel doesn't stand alone. WTW's acquisition of Newfront, the San Francisco-based specialty broker it closed in January in a deal worth up to US$1.3 billion, is framed explicitly as part of the same technology push. Newfront brings its own client-facing platform, Navigator, alongside separate agentic AI tools for automating parts of the placement process, and WTW's plan is to fuse all of it, Navigator, Neuron and its existing data and analytics tools, into a single digital ecosystem for brokers serving clients of every size.
WTW isn't alone in betting on this. Aon has spent the past year expanding its own Claims Copilot platform across North America, Asia Pacific and EMEA as part of a broader push into AI-enabled advisory tools, and used its own Q2 results this week to point to continued investment in AI as a driver of margin expansion. Marsh McLennan's chief executive, John Doyle, told analysts on his own Q2 call that the firm is "well-positioned to be an AI winner" because of its scale of proprietary data across risk, health and investments, a near-identical argument to the one WTW's leadership has made about Neuron.
The difference, for now, is specificity. Aon and Marsh have both talked up their data advantage and AI ambitions in fairly general terms on recent earnings calls. WTW is the only one of the three that has put a concrete figure on the investment (US$625 million), a margin target tied to it (30% by 2028), and named live use cases (cyber in North America, UK property, D&O trading with a named carrier partner). Whether that specificity reflects genuinely faster execution, or simply a broker choosing to disclose more detail than its rivals, is something only the next few quarters of adoption data will really answer. But for brokers weighing which platform to build workflows around, WTW is currently the one giving the clearest picture of what "AI in broking" looks like in practice rather than in a strategy slide.
